B-Raf IN 13
| Code | Size | Price |
|---|
| TAR-T67862-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
B-Raf IN 13 is a potent B-Raf inhibitor with anticancer activity.B-Raf IN 13 has an IC50 of 3.55 nM in the BRAF V600E enzyme assay.
CAS:
2573782-74-6
Molecular Weight:
439.89
Pathway:
MAPK
Purity:
0.9583
SMILES:
O=C1C2=C(N=CN1C)C=CC(OC3=CC(F)=CC(NS(=O)(=O)CCC)=C3Cl)=C2C
Target:
Raf
References
rPatrick MB, et al. Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders. WO2020261156A1.